ID   GLPX_ECOLI              Reviewed;         336 AA.
AC   P0A9C9; P11007; P28860; P28900; Q2M8M1;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 1.
DT   15-MAR-2017, entry version 101.
DE   RecName: Full=Fructose-1,6-bisphosphatase 1 class 2;
DE            Short=FBPase 1 class 2;
DE            EC=3.1.3.11;
DE   AltName: Full=D-fructose-1,6-bisphosphate 1-phosphohydrolase 1 class 2;
GN   Name=glpX; OrderedLocusNames=b3925, JW3896;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INDUCTION.
RC   STRAIN=K12 / MC4100 / ATCC 35695 / DSM 6574;
RX   PubMed=1400248; DOI=10.1128/jb.174.21.6981-6991.1992;
RA   Truniger V., Boos W., Sweet G.;
RT   "Molecular analysis of the glpFKX regions of Escherichia coli and
RT   Shigella flexneri.";
RL   J. Bacteriol. 174:6981-6991(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=8346018; DOI=10.1093/nar/21.15.3391;
RA   Plunkett G. III, Burland V., Daniels D.L., Blattner F.R.;
RT   "Analysis of the Escherichia coli genome. III. DNA sequence of the
RT   region from 87.2 to 89.2 minutes.";
RL   Nucleic Acids Res. 21:3391-3398(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   PRELIMINARY NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 228-336.
RC   STRAIN=K12;
RX   PubMed=2834327; DOI=10.1128/jb.170.5.2136-2142.1988;
RA   Morimyo M.;
RT   "Isolation and characterization of methyl viologen-sensitive mutants
RT   of Escherichia coli K-12.";
RL   J. Bacteriol. 170:2136-2142(1988).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBUNIT, KINETIC PARAMETERS,
RP   AND DISRUPTION PHENOTYPE.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=10986273; DOI=10.1128/JB.182.19.5624-5627.2000;
RA   Donahue J.L., Bownas J.L., Niehaus W.G., Larson T.J.;
RT   "Purification and characterization of glpX-encoded fructose 1, 6-
RT   bisphosphatase, a new enzyme of the glycerol 3-phosphate regulon of
RT   Escherichia coli.";
RL   J. Bacteriol. 182:5624-5627(2000).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF APOENZYME AND MUTANT ALA-61
RP   IN COMPLEXES WITH SUBSTRATE; METAL IONS AND PHOSPHATE, FUNCTION,
RP   CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, COFACTOR, ENZYME
RP   REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, REACTION
RP   MECHANISM, AND MUTAGENESIS OF LYS-29; GLU-57; GLU-59; ASP-61; ASP-85;
RP   GLU-88; THR-90; TYR-119; LYS-164; ARG-166; ASP-186; ASP-188; GLU-213;
RP   ARG-235 AND LYS-239.
RC   STRAIN=K12 / DH5-alpha;
RX   PubMed=19073594; DOI=10.1074/jbc.M808186200;
RA   Brown G., Singer A., Lunin V.V., Proudfoot M., Skarina T., Flick R.,
RA   Kochinyan S., Sanishvili R., Joachimiak A., Edwards A.M.,
RA   Savchenko A., Yakunin A.F.;
RT   "Structural and biochemical characterization of the type II fructose-
RT   1,6-bisphosphatase GlpX from Escherichia coli.";
RL   J. Biol. Chem. 284:3784-3792(2009).
CC   -!- FUNCTION: Catalyzes the hydrolysis of fructose 1,6-bisphosphate to
CC       fructose 6-phosphate. Is likely to be involved in gluconeogenesis
CC       during growth on glycerol. Also displays a low activity toward
CC       glucose 1,6-bisphosphate, and no activity against ribulose 1,5-
CC       bisphosphate, fructose 2,6-bisphosphate, or fructose 1-phosphate.
CC       {ECO:0000269|PubMed:10986273, ECO:0000269|PubMed:19073594}.
CC   -!- CATALYTIC ACTIVITY: D-fructose 1,6-bisphosphate + H(2)O = D-
CC       fructose 6-phosphate + phosphate. {ECO:0000269|PubMed:10986273,
CC       ECO:0000269|PubMed:19073594}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:10986273,
CC         ECO:0000269|PubMed:19073594};
CC       Note=Manganese. Mg(2+), Co(2+), Ni(2+), Ca(2+), Cu(2+) and Zn(2+)
CC       cannot support activity. {ECO:0000269|PubMed:10986273,
CC       ECO:0000269|PubMed:19073594};
CC   -!- ENZYME REGULATION: Competitively inhibited by low concentrations
CC       of phosphate (IC50 3.0 mM) and is also sensitive to Li(+) (IC50 70
CC       mM). Slightly activated by KCl. {ECO:0000269|PubMed:19073594}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=35 uM for fructose 1,6-bisphosphate (at pH 7.7 and room
CC         temperature) {ECO:0000269|PubMed:10986273,
CC         ECO:0000269|PubMed:19073594};
CC         KM=70 uM for fructose 1,6-bisphosphate (at pH 9.0 and 37 degrees
CC         Celsius) {ECO:0000269|PubMed:10986273,
CC         ECO:0000269|PubMed:19073594};
CC         KM=0.6 mM for Mn(2+) (at pH 9.0 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:10986273, ECO:0000269|PubMed:19073594};
CC         Vmax=3.3 umol/min/mg enzyme (at pH 7.7 and room temperature)
CC         {ECO:0000269|PubMed:10986273, ECO:0000269|PubMed:19073594};
CC         Vmax=8.8 umol/min/mg enzyme (at pH 9.0 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:10986273, ECO:0000269|PubMed:19073594};
CC         Note=The catalytic efficiency of GlpX is 3-fold higher than that
CC         of YggF, the other FBPase class 2 in E.coli.;
CC       pH dependence:
CC         Optimum pH is 7.5-8. {ECO:0000269|PubMed:19073594};
CC   -!- PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10986273,
CC       ECO:0000269|PubMed:19073594}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- INDUCTION: By glycerol and sn-glycerol-3-phosphate.
CC       {ECO:0000269|PubMed:1400248}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene grow normally on
CC       gluconeogenic substrates (succinate or glycerol).
CC       {ECO:0000269|PubMed:10986273}.
CC   -!- MISCELLANEOUS: E.coli K12 also possesses a FBPase class 1 (Fbp),
CC       which is the primary FBPase in E.coli and probably represents the
CC       main gluconeogenic FBPase.
CC   -!- SIMILARITY: Belongs to the FBPase class 2 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=M19644; Type=Miscellaneous discrepancy; Note=The C-terminal part of glpX was incorrectly assigned as being part of mvrA.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z11767; CAA77814.1; -; Genomic_DNA.
DR   EMBL; L19201; AAB03057.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76907.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77385.1; -; Genomic_DNA.
DR   EMBL; M19644; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; A45248; A45248.
DR   RefSeq; NP_418360.1; NC_000913.3.
DR   RefSeq; WP_001250644.1; NZ_LN832404.1.
DR   PDB; 1NI9; X-ray; 2.00 A; A=1-336.
DR   PDB; 2R8T; X-ray; 2.30 A; A=1-336.
DR   PDB; 3BIG; X-ray; 1.85 A; A=1-336.
DR   PDB; 3BIH; X-ray; 2.10 A; A=1-336.
DR   PDB; 3D1R; X-ray; 1.85 A; A=1-336.
DR   PDBsum; 1NI9; -.
DR   PDBsum; 2R8T; -.
DR   PDBsum; 3BIG; -.
DR   PDBsum; 3BIH; -.
DR   PDBsum; 3D1R; -.
DR   ProteinModelPortal; P0A9C9; -.
DR   SMR; P0A9C9; -.
DR   BioGrid; 4260756; 11.
DR   IntAct; P0A9C9; 6.
DR   STRING; 511145.b3925; -.
DR   EPD; P0A9C9; -.
DR   PaxDb; P0A9C9; -.
DR   PRIDE; P0A9C9; -.
DR   EnsemblBacteria; AAC76907; AAC76907; b3925.
DR   EnsemblBacteria; BAE77385; BAE77385; BAE77385.
DR   GeneID; 948424; -.
DR   KEGG; ecj:JW3896; -.
DR   KEGG; eco:b3925; -.
DR   PATRIC; 32123363; VBIEscCol129921_4042.
DR   EchoBASE; EB1479; -.
DR   EcoGene; EG11517; glpX.
DR   eggNOG; ENOG4105CBT; Bacteria.
DR   eggNOG; COG1494; LUCA.
DR   HOGENOM; HOG000241252; -.
DR   InParanoid; P0A9C9; -.
DR   KO; K02446; -.
DR   OMA; VIQGRLW; -.
DR   PhylomeDB; P0A9C9; -.
DR   BioCyc; EcoCyc:EG11517-MONOMER; -.
DR   BioCyc; MetaCyc:EG11517-MONOMER; -.
DR   BRENDA; 3.1.3.11; 2026.
DR   SABIO-RK; P0A9C9; -.
DR   UniPathway; UPA00138; -.
DR   EvolutionaryTrace; P0A9C9; -.
DR   PRO; PR:P0A9C9; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0042132; F:fructose 1,6-bisphosphate 1-phosphatase activity; IDA:EcoCyc.
DR   GO; GO:0030145; F:manganese ion binding; IDA:EcoCyc.
DR   GO; GO:0030388; P:fructose 1,6-bisphosphate metabolic process; IBA:GO_Central.
DR   GO; GO:0006094; P:gluconeogenesis; IBA:GO_Central.
DR   GO; GO:0006071; P:glycerol metabolic process; IEA:InterPro.
DR   CDD; cd01516; FBPase_glpX; 1.
DR   InterPro; IPR004464; FBPase_class-2/SBPase.
DR   PANTHER; PTHR30447:SF1; PTHR30447:SF1; 1.
DR   Pfam; PF03320; FBPase_glpX; 1.
DR   PIRSF; PIRSF004532; GlpX; 1.
DR   TIGRFAMs; TIGR00330; glpX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Carbohydrate metabolism; Complete proteome; Cytoplasm;
KW   Hydrolase; Manganese; Metal-binding; Reference proteome.
FT   CHAIN         1    336       Fructose-1,6-bisphosphatase 1 class 2.
FT                                /FTId=PRO_0000201100.
FT   REGION       88     90       Substrate binding.
FT                                {ECO:0000269|PubMed:19073594}.
FT   REGION      164    166       Substrate binding.
FT                                {ECO:0000269|PubMed:19073594}.
FT   REGION      186    188       Substrate binding.
FT                                {ECO:0000269|PubMed:19073594}.
FT   METAL        33     33       Manganese 1.
FT                                {ECO:0000305|PubMed:19073594}.
FT   METAL        57     57       Manganese 1.
FT                                {ECO:0000305|PubMed:19073594}.
FT   METAL        85     85       Manganese 2.
FT                                {ECO:0000305|PubMed:19073594}.
FT   METAL        88     88       Manganese 2.
FT                                {ECO:0000305|PubMed:19073594}.
FT   METAL       213    213       Manganese 2.
FT                                {ECO:0000305|PubMed:19073594}.
FT   BINDING     119    119       Substrate. {ECO:0000269|PubMed:19073594}.
FT   BINDING     210    210       Substrate; via amide nitrogen.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN      29     29       K->A: 2.4-fold increase in FBPase
FT                                activity, and no effect on substrate
FT                                affinity. {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN      57     57       E->A: Strong decrease in FBPase activity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN      59     59       E->A: 5.5-fold decrease in FBPase
FT                                activity, and 1.4-fold decrease in
FT                                substrate affinity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN      61     61       D->A: Great decrease in FBPase activity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN      85     85       D->A: Great decrease in FBPase activity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN      88     88       E->A: Strong decrease in FBPase activity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN      90     90       T->A: Strong decrease in FBPase activity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN     119    119       Y->A: Strong decrease in FBPase activity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN     164    164       K->A: Strong decrease in FBPase activity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN     166    166       R->A: Strong decrease in FBPase activity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN     186    186       D->A: 5-fold decrease in FBPase activity,
FT                                and 3-fold decrease in substrate
FT                                affinity. {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN     188    188       D->A: Great decrease in FBPase activity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN     213    213       E->A: Great decrease in FBPase activity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN     235    235       R->A: Nearly no effect on FBPase
FT                                activity, and 3-fold decrease in
FT                                substrate affinity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   MUTAGEN     239    239       K->A: 1.3-fold increase in FBPase
FT                                activity, and 1.4-fold decrease in
FT                                substrate affinity.
FT                                {ECO:0000269|PubMed:19073594}.
FT   HELIX         3      5       {ECO:0000244|PDB:3BIG}.
FT   HELIX         6     21       {ECO:0000244|PDB:3BIG}.
FT   TURN         22     25       {ECO:0000244|PDB:3BIG}.
FT   HELIX        29     44       {ECO:0000244|PDB:3BIG}.
FT   STRAND       50     58       {ECO:0000244|PDB:3BIG}.
FT   TURN         60     62       {ECO:0000244|PDB:3BIG}.
FT   STRAND       64     67       {ECO:0000244|PDB:3BIG}.
FT   STRAND       71     73       {ECO:0000244|PDB:3BIG}.
FT   STRAND       79     88       {ECO:0000244|PDB:3BIG}.
FT   HELIX        90     94       {ECO:0000244|PDB:3BIG}.
FT   STRAND      101    108       {ECO:0000244|PDB:3BIG}.
FT   STRAND      117    125       {ECO:0000244|PDB:3BIG}.
FT   HELIX       127    129       {ECO:0000244|PDB:3BIG}.
FT   HELIX       139    150       {ECO:0000244|PDB:3BIG}.
FT   HELIX       154    156       {ECO:0000244|PDB:3BIG}.
FT   STRAND      158    162       {ECO:0000244|PDB:3BIG}.
FT   HELIX       165    167       {ECO:0000244|PDB:3BIG}.
FT   HELIX       168    177       {ECO:0000244|PDB:3BIG}.
FT   STRAND      180    186       {ECO:0000244|PDB:3BIG}.
FT   HELIX       189    194       {ECO:0000244|PDB:3BIG}.
FT   STRAND      204    210       {ECO:0000244|PDB:3BIG}.
FT   HELIX       211    224       {ECO:0000244|PDB:3BIG}.
FT   STRAND      227    233       {ECO:0000244|PDB:3BIG}.
FT   HELIX       235    237       {ECO:0000244|PDB:3BIG}.
FT   HELIX       244    257       {ECO:0000244|PDB:3BIG}.
FT   TURN        258    260       {ECO:0000244|PDB:3BIG}.
FT   STRAND      265    268       {ECO:0000244|PDB:3BIG}.
FT   HELIX       269    272       {ECO:0000244|PDB:3BIG}.
FT   STRAND      278    286       {ECO:0000244|PDB:3BIG}.
FT   STRAND      289    291       {ECO:0000244|PDB:3BIG}.
FT   STRAND      295    297       {ECO:0000244|PDB:3BIG}.
FT   STRAND      300    309       {ECO:0000244|PDB:3BIG}.
FT   TURN        310    313       {ECO:0000244|PDB:1NI9}.
FT   STRAND      315    323       {ECO:0000244|PDB:3BIG}.
SQ   SEQUENCE   336 AA;  35852 MW;  DEC2A477E5C4062E CRC64;
     MRRELAIEFS RVTESAALAG YKWLGRGDKN TADGAAVNAM RIMLNQVNID GTIVIGEGEI
     DEAPMLYIGE KVGTGRGDAV DIAVDPIEGT RMTAMGQANA LAVLAVGDKG CFLNAPDMYM
     EKLIVGPGAK GTIDLNLPLA DNLRNVAAAL GKPLSELTVT ILAKPRHDAV IAEMQQLGVR
     VFAIPDGDVA ASILTCMPDS EVDVLYGIGG APEGVVSAAV IRALDGDMNG RLLARHDVKG
     DNEENRRIGE QELARCKAMG IEAGKVLRLG DMARSDNVIF SATGITKGDL LEGISRKGNI
     ATTETLLIRG KSRTIRRIQS IHYLDRKDPE MQVHIL
//
